TARPLIN, DOWNS & YOUNG, LLC

Lobbying for BRISTOL MYERS SQUIBB · Global biopharma company developing innovative medicines

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · New York · House · Senate · $60,000.00 income · posted Jul 21, 2025

Lobbying activity 3

Medicare/Medicaid

IRA, Medicare & Medicaid payment and coverage issues

Health Issues

prescription drug access and affordability, pricing, transparency, 340B

Budget/Appropriations

federal budget issues

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.